All Releases
 |
PPD Named Best Contract Research Organization in Asia at 2010 Vaccine Industry Excellence Awards
Jun 16, 2010
|
9.7 KB |
| |
WILMINGTON, N.C. (June 16, 2010) - PPD, Inc. (Nasdaq: PPDI) today announced it has been named Best Contract Research Organization (CRO) in Asia at the World Vaccine Congress' inaugural 2010 Vaccine Industry Excellence (ViE) Asia Awards held in Singapore on June 9. The award recognizes PPD's quality of services provided in Asia and its lon...
|
|
PPD Names Mike Wilkinson as Executive Vice President and Chief Information Officer, Paul Colvin as Executive Vice President of Global Clinical Development
Jun 15, 2010
|
10.4 KB |
| |
WILMINGTON, N.C. (June 15, 2010) - PPD, Inc. (Nasdaq: PPDI) today announced it has appointed Mike Wilkinson, Ph.D., as executive vice president and chief information officer and Paul Colvin as executive vice president of global clinical development effective June 30.
As executive vice president and chief information officer, Dr....
|
|
PPD and Furiex Announce Completion of Spin-off
Jun 15, 2010
|
11.1 KB |
| |
WILMINGTON, N.C., and MORRISVILLE, N.C. (June 15, 2010) - PPD, Inc. (Nasdaq: PPDI) and Furiex Pharmaceuticals, Inc. (Nasdaq: FURX) announced today the successful completion of the spin-off of Furiex. As previously announced, PPD received a private letter ruling from the Internal Revenue Service that the dividend of common stock of Furiex ...
|
|
PPD Rated One of Top CROs in Europe in 2010
Jun 11, 2010
|
9.4 KB |
| |
Company earns number two ranking in CenterWatch's European site survey
WILMINGTON, N.C. (June 11, 2010) - PPD, Inc. (Nasdaq: PPDI) today announced it has been rated one of Europe's top contract research organizations (CROs) in the 2010 CenterWatch European Site Survey. The company earned a number two ranking amo...
|
|
PPD Announces Effectiveness of Furiex Pharmaceuticals' Registration Statement on Form 10
May 27, 2010
|
10.3 KB |
| |
WILMINGTON, N.C. (May 27, 2010) - PPD, Inc. (Nasdaq: PPDI) announced today that, in connection with its proposed spin-off of Furiex Pharmaceuticals, Inc., the Securities and Exchange Commission has declared effective Furiex Pharmaceuticals' Registration Statement on Form 10.
Furiex Pharmaceuticals' common stock is expected to beg...
|
|
PPD Launches Expert Community for Online, Interactive Exchange of Industry Viewpoints
May 26, 2010
|
10.5 KB |
| |
WILMINGTON, N.C. (May 26, 2010) - PPD, Inc. (Nasdaq: PPDI) today announced it has launched Expert Community, an online, interactive area on its corporate website, www.ppdi.com, where company and other industry professionals can engage in a robust exchang...
|
|
PPD Sets Record and Distribution Dates for Spin-Off of Furiex Pharmaceuticals
May 24, 2010
|
11.0 KB |
| |
WILMINGTON, N.C. (May 24, 2010) - PPD, Inc. (Nasdaq: PPDI) announced today its board of directors has set the shareholder of record and distribution dates in connection with the spin-off of its wholly-owned subsidiary, Furiex Pharmaceuticals, Inc. Shareholders of record of PPD on June 1, 2010, will receive on June 14, 2010, a pro-rata div...
|
|
PPD Declares Second Quarter Dividend
May 20, 2010
|
8.6 KB |
| |
WILMINGTON, N.C. (May 20, 2010) - PPD, Inc. (Nasdaq: PPDI) today announced that its board of directors declared a cash dividend for the second quarter of 2010 under its annual cash dividend policy. The quarterly cash dividend will equal $0.15 per share. The record date for the second quarter dividend is June 15, 2010, and the payment date...
|
|
PPD Opens Pharmacovigilance and Medical Communications Center in Sofia, Bulgaria
May 5, 2010
|
11.3 KB |
| |
WILMINGTON, N.C. (May 5, 2010) - PPD, Inc. (Nasdaq: PPDI) today announced the opening of a pharmacovigilance and medical communications center in Sofia, Bulgaria, delivering its full range of drug safety, medical information and medical writ...
|
|
PPD's Contract Research Facility in Athlone, Ireland, Awarded Licenses by Irish Medicines Board
Apr 27, 2010
|
9.6 KB |
| |
WILMINGTON, N.C. (April 27, 2010) - PPD, Inc. (Nasdaq: PPDI) today announced its contract research facility in Athlone, Ireland, has been awarded manufacturer licenses by the Irish Medicines Board (IMB). The licenses support investigational medicinal products and marketed products and provide laboratory certifications for quality control ...
|
|
PPD Opens Vaccine Clinical Research Center in Taizhou, China
Apr 26, 2010
|
10.1 KB |
| |
WILMINGTON, N.C. (April 26, 2010) - PPD, Inc. (Nasdaq: PPDI) today announced it has opened a vaccine clinical research center in Taizhou, China, further strengthening its clinical research and development services in one of the country's major regions for conducting vaccine studies. Through the center, PPD will provide clinical monitoring...
|
|
PPD Confirms Takeda Receives NDA Approval of NESINA® (Alogliptin) from Japanese Ministry of Health, Labour and Welfare
Apr 26, 2010
|
9.4 KB |
| |
WILMINGTON, N.C. (April 26, 2010) - PPD, Inc. (Nasdaq: PPDI) today confirmed that Takeda Pharmaceutical Company Limited's new drug application for NESINA® (alogliptin), a highly selective DPP-4 inhibitor for the treatment of type 2 diabetes, was approved by the Japanese Ministry of Health, Labour and Welfare on April 16. PPD'...
|
|
PPD Reports First Quarter 2010 Financial Results
Apr 26, 2010
|
70.9 KB |
| |
Highlights:
$607 million in gross authorizations; $480 million in net authorizations
Cash flow from operations of $62 million
$675 million in cash and investments
Strengthens global laboratory business
Compound partnering spin-off on target for mid-2010...
|
|
PPD to Present at World Vaccines Congress 2010
Apr 19, 2010
|
10.7 KB |
| |
WILMINGTON, N.C. (April 19, 2010) - PPD, Inc. (Nasdaq: PPDI) today announced Mark Esser, Ph.D., associate director of immunology, and Lisa Kierstead, Ph.D., associate director, labs, will present at the 10th annual World Vaccine Congress 2010 Conference in Chantilly, Va., on April 19-22.
Dr. Esser will discuss the role of vaccin...
|
|
PPD to Present at Partnerships in Clinical Trials Conference
Apr 12, 2010
|
11.1 KB |
| |
WILMINGTON, N.C. (April 12, 2010) - PPD, Inc. (Nasdaq: PPDI) today announced several of its experts will speak at the 19th annual Partnerships in Clinical Trials 2010 Conference in Orlando, Fla., on April 12-14. As a keynote presenter, Bill Sharbaugh, chief operating officer of PPD, will discuss considerations for achieving and maintainin...
|
|
PPD Announces First Quarter 2010 Earnings Release, Webcast and Conference Call
Apr 1, 2010
|
8.6 KB |
| |
WILMINGTON, N.C. (April 1, 2010) - PPD, Inc. (Nasdaq: PPDI) will release its first quarter 2010 financial results on Monday, April 26, 2010, after the market closes. The earnings release will be available on the PPD Web site at www.ppdi.com.
On Tuesday, April 27, 2010, at 8:30 a.m. ET, PPD wil...
|
|
PPD to Present at Late Phase Drug Development Conference
Mar 23, 2010
|
10.5 KB |
| |
WILMINGTON, N.C. (March 23, 2010) - PPD, Inc. (Nasdaq: PPDI) today announced Deborah Covington, Dr.P.H., global head of observational studies and pregnancy registries, will join a panel of experts at the Late Phase Drug Development World Americas conference i...
|
|
PPD Strengthens Global Risk Management Services with Appointment of REMS Expert
Mar 23, 2010
|
9.6 KB |
| |
WILMINGTON, N.C. (March 23, 2010) - PPD, Inc. (Nasdaq: PPDI) today announced it has named Frank Gallo as executive director of risk management, strengthening its expertise in risk evaluation and mitigation strategies (REMS). Mr. Gallo will lead the d...
|
|
PPD Launches New Vaccines & Biologics Center of Excellence
Mar 23, 2010
|
11.8 KB |
| |
WILMINGTON, N.C. (March 23, 2010) - PPD, Inc. (Nasdaq: PPDI) today announced it is launching the PPD Vaccines & Biologics Center of Excellence, a first-in-kind comprehensive network of integrated, world-class laboratory services focused specifically on vaccine and biologic drug development. The cen...
|
|
PPD and Southern Research Institute Sign Agreement for Pandemic and Seasonal Influenza Vaccine Clinical Research Services
Mar 17, 2010
|
11.6 KB |
| |
WILMINGTON, N.C. and BIRMINGHAM, Ala. (March 17, 2010)-PPD and Southern Research Institute today announced they have formed a collaborative agreement in pandemic and seasonal influenza vaccine research and development to provide clients a full spectrum of influenza vaccine development services by collaborating on client bids and pr...
|
|
|
